3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis

Arch Pharm (Weinheim). 2008 Jun;341(6):357-64. doi: 10.1002/ardp.200700229.

Abstract

Three-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for chromone derivatives against HIV-1 protease using molecular field analysis (MFA) with genetic partial least square algorithms (G/PLS). Three different alignment methods: field fit, pharmacophore-based, and receptor-based were used to derive three MFA models. All models produced good predictive ability with high cross-validated r(2) (r(2) (cv)), conventional r(2), and predictive r(2)(r(2)(pred)) values. The receptor-based MFA showed the best statistical results with r(2) (cv) = 0.789, r(2)= 0.886, and r(2)(pred) = 0.995. The result obtained from the receptor-based model was compared with the docking simulation of the most active compound 21 in this chromone series to the binding pocket of HIV-1 protease (PDB entry 1AJX). It was shown that the MFA model related well with the binding structure of the complex and can provide guidelines to design more potent HIV-1 protease inhibitors.

MeSH terms

  • Algorithms
  • Binding Sites
  • Chromones / chemistry*
  • Drug Design
  • HIV Protease / chemistry*
  • HIV Protease Inhibitors / chemistry*
  • Least-Squares Analysis
  • Models, Molecular
  • Molecular Conformation
  • Quantitative Structure-Activity Relationship*

Substances

  • Chromones
  • HIV Protease Inhibitors
  • HIV Protease
  • p16 protease, Human immunodeficiency virus 1